The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain ...
CNBC's Becky Quick reports on the latest news.
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...
A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...